Targeting dendritic cells with biomaterials: developing the next generation of vaccines

Sai T. Reddy, Melody A. Swartz, Jeffrey A. Hubbell

Research output: Contribution to journalReview articlepeer-review

346 Scopus citations


Current vaccine and immunotherapy technology faces ongoing challenges in both efficacy and practicality: many chronic diseases cannot yet be addressed by vaccination, and several vaccines that do function well require multiple injections, which is a substantial limitation in various parts of the world. A possible key to developing the next generation of vaccines is the ability to deliver antigen to dendritic cells (DCs) more specifically and induce the subsequent activation of T-cell immunity. However, antigen delivery to, and activation of, DCs is a complex problem, involving antigen transport to DC-rich areas, DC binding and antigen uptake, and antigen processing and presentation. Addressing these challenges requires novel and multidisciplinary approaches, for example, the application of biomaterials to immunotechnology. Here, we review the latest advances in biomaterial drug vehicles, such as polymer microparticles and nanoparticles, and liposomes, that are being used to target DCs in new strategies for vaccination.

Original languageEnglish (US)
Pages (from-to)573-579
Number of pages7
JournalTrends in Immunology
Issue number12
StatePublished - Dec 1 2006

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Targeting dendritic cells with biomaterials: developing the next generation of vaccines'. Together they form a unique fingerprint.

Cite this